Gene · 55244
Papers1,509
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,509
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Metformin Pharmacogenetics in Heart Failure Patients with Reduced Ejection Fraction: Impact on Metformin and Growth Differentiation Factor-15 Plasma Levels. | Clin Pharmacokinet | 2026 | 42804152 | PubTator, text mining | PubMed |
| Genetic Variants Involved in Metformin Pharmacokinetics in the Chilean Population. | Genes (Basel) | 2026 | 42793008 | PubTator, text mining | PubMed |
| Creatinine-Cystatin C Discrepancy and Renal Transporter Polymorphisms in Japanese Patients with Breast Cancer Receiving Abemaciclib. | Clin Pharmacol Ther | 2026 | 42773505 | PubTator, text mining | PubMed |
| In vitro assessments for pharmacokinetic drug-drug interaction potential of vornorexant, a novel dual orexin 1/2 receptor antagonist. | Xenobiotica | 2026 | 42693680 | PubTator, text mining | PubMed |
| Reconstitution and Transport Analysis of Multidrug Transporters. | Methods Mol Biol | 2026 | 42681248 | PubTator, text mining | PubMed |
| Berberine-Drug Interactions: Mechanisms, Clinical Relevance and Risk Stratification-A Narrative Review. | Pharmaceuticals (Basel) | 2026 | 42653808 | PubTator, text mining | PubMed |
| Population pharmacokinetic modeling of amisulpride drug interactions and a transporter binding analysis. | Eur J Clin Pharmacol | 2026 | 42518010 | PubTator, text mining | PubMed |
| Transporter gene variants influencing metformin pharmacokinetics and pharmacodynamics common in European populations: a pharmacogenetic narrative review. | Front Pharmacol | 2026 | 42403712 | PubTator, text mining | PubMed |
| Effects of Trimethoprim on Three Previously Proposed Putative Biomarkers for OCT2/MATE-Mediated Renal Drug-Drug Interactions in Healthy Volunteers. | Clin Pharmacol Ther | 2026 | 42400553 | PubTator, text mining | PubMed |
| Integrating CYP2D6 and MATE1 activities in drug-drug interaction assessment: Insights from newly developed antidepressant drug ammoxetine. | J Pharmacol Exp Ther | 2026 | 42242161 | PubTator, text mining | PubMed |
| Integrative Mapping of Regulatory Variation in African American Hepatocytes Using Colocalization and MPRA: Toward Precision Drug Response. | Res Sq | 2026 | 42239751 | PubTator, text mining | PubMed |
| A whole genomic CRISPR-Cas9 screen identifies the amino acid transporter SLC43A1 (LAT3) as a major determinant of oxaliplatin sensitivity in colorectal cancer cells. | Mol Cancer Ther | 2026 | 42227585 | PubTator, text mining | PubMed |
| Reduction in estimated glomerular filtration rate observed with doravirine is caused by inhibition of organic cation transporter 2. | Drug Metab Dispos | 2026 | 42150384 | PubTator, text mining | PubMed |
| Identification of Brimonidine as a Novel Substrate of Organic Cation Transporters OCT2 and MATE1 Expressed in Human Eye. | Invest Ophthalmol Vis Sci | 2026 | 41925694 | PubTator, text mining | PubMed |
| Drug-drug interactions of antidepressant ammoxetine mediated by cytochrome P450 2D6 and multidrug and toxin extrusion protein 1: From in vitro mechanistic investigations to in vivo validation. | J Pharmacol Exp Ther | 2026 | 41880803 | PubTator, text mining | PubMed |
| Solute carrier-mediated membrane transport of hepatotoxic phytochemicals and synthetic drugs. | Life Sci | 2026 | 41862051 | PubTator, text mining | PubMed |
| Changes in Metabolic Parameters After Switching From Efavirenz to Dolutegravir-Based Regimen: A Cohort Study in Thai People Living With HIV. | J Int Assoc Provid AIDS Care | 2026 | 41805453 | PubTator, text mining | PubMed |
| Targeting ferroptosis in cancer: from mechanistic insights to therapeutic approaches. | Mol Biomed | 2026 | 41772328 | PubTator, text mining | PubMed |
| Remdesivir in COVID-19: pros and cons. | Front Pharmacol | 2026 | 41769697 | PubTator, text mining | PubMed |
| Evaluating the Impact of Putative Metformin Targets on Cancer Outcomes: A Drug-Target Mendelian Randomization Study. | Diabetes Obes Metab | 2026 | 41755790 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55244/papers